Drugs / MAGE-3.A1 peptide
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00145145 | Jan → Apr 2005 | melanoma | Ludwig Institute for Cancer Research | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MAGE-3.A1 peptide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00145145 ↗ |
| Modality | Peptide | “MAGE-3.A1 peptide (300 µg)” NCT00145145 ↗ |